Company news
ProtoKinetix, Inc. news in 2020
ProtoKinetix, Inc.'s news releases, calls and decks from 2020, newest first.
Research Paper Showing ProtoKinetix AAGP® Enhanced Stem Cell Derived Retina Precursor Cells Restoration of Vision
November 24, 2020
ProtoKinetix AAGP® Restores Vision in Blind Test Subjects
September 15, 2020
Ammendments to ProtoKinetix AAGP® Protocol for Continuation of Phase 1 Human Trials Have Been Approved by Health Canada
August 27, 2020
ProtoKinetix AAGP® Moves to Whole Organ Transplantation Testing
August 14, 2020
Amendments to ProtoKinetix AAGP® Protocol for Continuation of Phase 1 Human Trials by the University of Alberta Submitted to Health Canada
July 13, 2020
ProtoKinetix AAGP® Dry Eye Program Advancing
July 7, 2020
ProtoKinetix AAGP® Exhibits Efficacy and Safety in Model of Dry Eye Disease
April 6, 2020
ProtoKinetix Ready to Ship AAGP® to the University of Alberta for the Continuation of Phase 1 Human Trials
March 24, 2020
ProtoKinetix Files for Patent Protection for AAGP® to be Used in Dry Eye Disease
March 19, 2020
ProtoKinetix Announces Progress in the use of AAGP® in Cardiovascular Medicine
February 19, 2020
ProtoKinetix Files for Patent Protection for the Use of AAGP® in Transplant Medicine
February 11, 2020
ProtoKinetix Takes Delivery of GMP AAGP® PKX-001 Dedicated for Phase 1 Trial
January 24, 2020
ProtoKinetix AAGP® Dry Eye Therapy Testing Results
January 6, 2020
Decks in 2020
- Investor Presentation (September 2020)
Investor deck · 26 slides · September 2020